SMAD5 — SMAD Family Member 5
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SMAD5 — SMAD Family Member 5</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SMAD5</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SMAD family member 5</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>5q31.1</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/4090" target="_blank">4090</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113657" target="_blank">ENSG00000113657</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/603109" target="_blank">603109</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q99717" target="_blank">Q99717</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>465 amino acids</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Receptor-regulated SMAD (R-SMAD)</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>BMP Signaling, TGF-β Signaling</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
SMAD5 — SMAD Family Member 5
Overview
SMAD5 (SMAD family member 5) is a critical signal transduction protein that functions as a receptor-regulated SMAD (R-SMAD) in the bone morphogenetic protein (BMP) signaling pathway. As a key mediator of BMP signaling, SMAD5 plays essential roles in embryonic development, tissue patterning, and cellular homeostasis throughout the body[@massague2000].
In the nervous system, SMAD5 has emerged as a crucial regulator of neurodevelopment and neuronal function. It mediates BMP-induced signaling that influences neural stem cell proliferation and differentiation, dopaminergic neuron development, synaptic plasticity, and overall brain function. Dysregulation of SMAD5 signaling has been implicated in the pathogenesis of [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other [neurodegenerative conditions](/diseases/neurodegeneration-overview)[@flanders2004][@chen2018][@wang2020].
The SMAD5 gene is located on chromosome 5q31.1 and encodes a 465-amino acid protein that transduces signals from BMP receptors to the nucleus, where it regulates gene transcription. The protein contains conserved MH1 (Mad-homology 1) and MH2 (Mad-homology 2) domains that facilitate DNA binding and protein-protein interactions, respectively.
Gene Structure and Expression
Genomic Organization
The SMAD5 gene spans approximately 37.5 kb on chromosome 5q31.1 and consists of 9 exons. The gene exhibits complex regulation with multiple transcription start sites and alternative splicing variants.
| Feature | Value |
|---------|-------|
| Chromosome | 5 |
| Band | q31.1 |
| Genomic Coordinates (GRCh38) | chr5:147,852,342-147,889,891 |
| Strand | Positive (+) |
| Ensembl ID | ENSG00000113657 |
| NCBI Gene ID | 4090 |
| OMIM | 603109 |
| Protein Length | 465 amino acids |
Protein Domain Architecture
The SMAD5 protein contains two conserved domains:
MH1 Domain (N-terminal, residues 1-138):
- DNA-binding function
- Recognizes specific DNA sequences (SBE - SMAD binding elements)
- Contains nuclear localization signal
- Inhibitory regulatory region that blocks MH2 function in inactive state
MH2 Domain (C-terminal, residues 227-465):
- Protein-protein interactions
- Trimer formation capability
- Transcriptional co-activator binding
- Contains C-terminal serine phosphorylation sites (S463-S465)
- Mediates interaction with SMAD4
Tissue Expression
SMAD5 exhibits widespread expression with particular importance in:
| Tissue | Expression Level | Significance |
|--------|-----------------|--------------|
| Brain | High | Neurogenesis, neuronal function |
| Lung | High | Development, repair |
| Heart | High | Cardiac development |
| Bone | High | Osteogenesis |
| Neural stem cells | Very high | NSC maintenance and differentiation |
| Neurons | Moderate-High | Synaptic function |
| Astrocytes | Moderate | Neuroinflammation regulation |
| Oligodendrocytes | Moderate | Myelination |
In the brain, SMAD5 is expressed throughout development and in adult life, with particular enrichment in:
- Subventricular zone (SVZ) - neurogenic niche
- Hippocampal dentate gyrus - adult neurogenesis
- Cerebral cortex - cortical development
- Substantia nigra - dopaminergic neurons
Canonical BMP-SMAD5 Signaling Pathway
Signal Initiation
The canonical SMAD5 pathway begins with BMP ligand binding:
Mermaid diagram (expand to render)
BMP ligand binding: BMP2, BMP4, BMP6, or BMP7 bind to type I receptors (BMPR1A/ALK3 or BMPR1B/ALK6)
Type II receptor recruitment: BMP type II receptors (BMPR2, ACVR2A) are recruited to the complex
Signal transduction: The type II receptor phosphorylates the type I receptor's GS domain (glycine-serine rich region)
SMAD5 activation: Activated type I receptor directly phosphorylates SMAD5 at C-terminal serine residues (S463-S465)SMAD5 Activation and Nuclear Translocation
Upon phosphorylation:
Conformational change: Phosphorylation induces conformational change, releasing MH1 domain auto-inhibition
Complex formation: Phosphorylated SMAD5 forms trimeric complexes with SMAD4 (co-SMAD)
Nuclear import: The SMAD complex translocates to the nucleus
Transcriptional regulation: SMAD5-SMAD4 complexes bind to SMAD-binding elements (SBE) in target gene promoters
Co-activator recruitment: Transcriptional co-activators (CBP/p300, Runx proteins) are recruited
Gene expression: Target genes involved in cell fate, differentiation, and survival are regulated
Role in the Nervous System
Neural Stem Cell Biology
SMAD5 is a critical regulator of neural stem cell (NSC) function[@zhang2022][@luo2021]:
Proliferation:
- BMP-SMAD5 signaling promotes NSC proliferation in the subventricular zone
- Essential for maintaining the NSC pool during development
- Balanced signaling required for proper stem cell numbers
Differentiation:
- SMAD5 mediates BMP-induced neuronal differentiation
- Influences astrocyte versus neuronal fate decisions
- Regulates oligodendrocyte lineage specification
Maintenance:
- Continuous BMP-SMAD5 signaling contributes to NSC maintenance
- Self-renewal regulation through feedback mechanisms
- Age-related changes in SMAD5 affect NSC function
Dopaminergic Neuron Development
SMAD5 plays crucial roles in dopaminergic neuron biology[@morimoto2021]:
- Development: BMP signaling via SMAD5 promotes dopaminergic neuron differentiation during embryogenesis
- Survival: SMAD5-mediated signaling provides trophic support to dopaminergic neurons
- Vulnerability: Altered SMAD5 signaling may contribute to dopaminergic neuron vulnerability in [Parkinson's disease](/diseases/parkinsons-disease)
Synaptic Plasticity and Memory
The SMAD5 pathway contributes to synaptic function[@liu2020]:
- Long-term potentiation (LTP): BMP-SMAD5 signaling modulates synaptic strengthening
- Long-term depression (LTD): Involved in synaptic weakening mechanisms
- Dendritic spine morphology: Regulates spine formation and maintenance
- Memory formation: Essential for certain forms of learning and memory
Neuroprotection
SMAD5 signaling exhibits neuroprotective properties[@yang2023]:
- Oxidative stress protection: BMP7-SMAD5 axis provides protection against oxidative damage
- Excitotoxicity mitigation: Modulates glutamate-induced toxicity
- Apoptosis inhibition: Prevents neuronal cell death through pro-survival signaling
Disease Associations
Alzheimer's Disease
SMAD5 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis through multiple mechanisms[@chen2018][@he2019][@xie2021]:
Amyloid-beta metabolism:
- SMAD5 signaling interacts with amyloid precursor protein (APP) processing
- Altered SMAD5 affects amyloid-beta production and clearance
- Cross-talk between BMP and amyloid pathways
Tau pathology:
- SMAD5 interacts with tau phosphorylation pathways
- BMP-SMAD5 signaling influences tau aggregation
- Therapeutic modulation may affect tau pathology
Neuroinflammation:
- SMAD5 in astrocytes regulates inflammatory responses
- Microglial BMP signaling modulates neuroinflammation
- Cytokine cross-talk affects SMAD5 expression
Neuronal apoptosis:
- SMAD5 mediates amyloid-beta-induced neuronal apoptosis
- Dysregulated signaling contributes to neuronal loss
- Neuroprotective strategies may involve SMAD5 modulation
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), SMAD5 involvement includes[@wang2020][@tanner2021][@cheng2023]:
Alpha-synuclein interaction:
- SMAD5 signaling may influence alpha-synuclein aggregation
- BMP pathway modulation affects protein clearance
- Therapeutic targeting of SMAD5 may provide benefits
Dopaminergic neuron survival:
- Loss of SMAD5 signaling contributes to dopaminergic neuron death
- BMP-SMAD5 neuroprotective pathways are compromised
- Gene therapy approaches targeting SMAD5 are being explored
Epigenetic regulation:
- SMAD5 expression is epigenetically altered in PD
- DNA methylation affects SMAD5 promoter activity
- Histone modifications influence SMAD5 signaling
Other Neurodegenerative Conditions
SMAD5 dysregulation is also implicated in:
Amyotrophic Lateral Sclerosis (ALS):
- Altered BMP-SMAD5 signaling in motor neurons
- Glial contributions to disease through SMAD5 modulation
- Potential therapeutic target
Multiple Sclerosis:
- Demyelination involves BMP-SMAD5 pathway alterations
- Oligodendrocyte differentiation affected
- Remyelination strategies may target SMAD5
Huntington's Disease:
- Altered BMP signaling including SMAD5
- neuronal dysfunction related to SMAD5 dysregulation
Molecular Mechanisms in Neurodegeneration
Mitochondrial Dysfunction
SMAD5 intersects with mitochondrial biology[@saito2022]:
Mermaid diagram (expand to render)
Neuroinflammation
SMAD5 modulates inflammatory responses in the CNS[@khalil2022][@muller2020]:
- Astrocyte reactivity: BMP-SMAD5 signaling regulates astrocyte activation
- Microglial polarization: Influences microglial phenotype transitions
- Cytokine production: Modulates inflammatory cytokine release
- Blood-brain barrier: Affects BBB integrity through inflammatory mechanisms
Protein Aggregation
SMAD5 interacts with protein aggregation processes:
- Amyloid-beta aggregation: Altered SMAD5 affects aggregation kinetics
- Tau pathology: SMAD5 influences tau phosphorylation and aggregation
- Alpha-synuclein: BMP-SMAD5 pathway modulation affects synucleinopathy
Cellular Stress Responses
SMAD5 participates in stress response pathways:
- Oxidative stress: Regulates antioxidant gene expression
- ER stress: Modifies unfolded protein response
- DNA damage: Influences DNA repair mechanisms
Therapeutic Implications
Drug Development Targets
SMAD5 represents a promising therapeutic target:
BMP receptor agonists: Enhance SMAD5 activation for neuroprotection
SMAD5 modulators: Direct modulators of SMAD5 activity
Phosphatase inhibitors: Prevent SMAD5 dephosphorylation
Transcriptional modulators: Target SMAD5-cofactor interactionsGene Therapy Approaches
- AAV-mediated SMAD5 delivery: Viral vector delivery to affected brain regions
- BMP ligand gene therapy: Express BMP ligands to activate SMAD5 pathway
- CRISPR-based approaches: Target SMAD5 for upregulation
Biomarker Potential
SMAD5-related biomarkers could include:
- Phospho-SMAD5 levels in cerebrospinal fluid
- SMAD5 expression in peripheral blood cells
- Genetic variants as risk modifiers
- Downstream transcriptional signatures
Challenges
- Dose-dependent effects: Both excessive and insufficient SMAD5 signaling can be problematic
- Tissue specificity: Targeting specific brain regions remains challenging
- Pathway complexity: Extensive cross-talk with other signaling pathways
- Temporal considerations: Timing of intervention may be critical
Non-Canonical SMAD5 Signaling
Beyond the canonical pathway, SMAD5 participates in non-SMAD signaling:
MAPK Pathway Interactions
- ERK activation: SMAD5 can activate ERK/MAPK signaling
- p38 signaling: Cross-talk with p38 pathway
- JNK pathway: Interactions with stress-activated kinases
PI3K/AKT Pathway
- AKT activation: SMAD5 can influence AKT signaling
- Cell survival: Convergence on pro-survival pathways
- mTOR regulation: Interactions with metabolic pathways
Rho GTPase Pathways
- Cytoskeletal regulation: SMAD5 affects cytoskeletal dynamics
- Migration: Influences cell migration mechanisms
- Neurite outgrowth: Modulates neuronal process formation
Interactions with Other Proteins
SMAD Family Interactions
| SMAD | Interaction | Functional Outcome |
|------|-------------|-------------------|
| SMAD4 | Complex formation | Transcriptional regulation |
| SMAD1 | Heterodimerization | Shared target genes |
| SMAD8/SMAD9 | Functional redundancy | Compensatory signaling |
Transcriptional Co-factors
- CBP/p300: Histone acetyltransferases for transcriptional activation
- Runx proteins: Transcriptional regulators
- FoxH1: Forkhead transcription factor
- Homeobox proteins: Developmental regulators
Signaling Pathway Cross-talk
SMAD5 interacts with numerous pathways:
- TGF-β/SMAD2/3: Extensive cross-talk between TGF-β and BMP branches
- Wnt/β-catenin: Convergence on common target genes
- Notch signaling: Coordinated developmental regulation
- Hedgehog pathway: Integrated developmental signaling
- JAK-STAT pathway: Cytokine-mediated interactions
Genetic Variants and Polymorphisms
Known Variants
Population studies have identified several SMAD5 polymorphisms:
| Variant | Location | Potential Effect |
|---------|----------|-----------------|
| rs* (promoter) | 5' UTR | Altered expression |
| rs* (coding) | Exon | Amino acid change |
| rs* (intronic) | Intron | Splicing regulation |
Disease Associations
- GWAS hits in SMAD5 region for various traits
- Association with bone mineral density
- Potential modifier effects in neurodegenerative diseases
Mouse Models
Several SMAD5 mouse models have been developed:
Conditional Knockout Models:
- Nestin-Cre: Neural stem cell-specific deletion
- Synapsin-Cre: Neuron-specific deletion
- GFAP-Cre: Astrocyte-specific deletion
- CamKIIa-Cre: Excitatory neuron-specific deletion
Phenotypic Characteristics:
- Embryonic lethality in complete knockouts
- Neural tube defects in conditional models
- Altered neurogenesis in NSC-specific knockouts
- Synaptic dysfunction in neuronal knockouts
Transgenic Models:
- SMAD5 overexpression lines
- Constitutively active SMAD5
- Dominant-negative SMAD5
Cell Culture Models
- Neural stem cells: Primary NSC cultures for differentiation studies
- Neuronal cultures: Primary cortical and hippocampal neurons
- Astrocyte cultures: For neuroinflammation studies
- Organoid systems: Brain organoids for developmental studies
- iPSC-derived neurons: Patient-specific models
Small Molecule Modulators
| Compound | Target | Effect | Application |
|----------|--------|--------|-------------|
| LDN-193189 | BMPR1A/ALK2 | Inhibitor | Blocking BMP signaling |
| Dorsomorphin | BMPR1A | Inhibitor | Pathway inhibition |
| BMP4 | BMPR1A/ALK3 | Agonist | Pathway activation |
| BMP7 | BMPR1A/ALK2 | Agonist | Neuroprotection |
Clinical and Therapeutic Considerations
Clinical Biomarkers
SMAD5-related clinical markers include:
Diagnostic Markers:
- Phospho-SMAD5 levels in CSF
- SMAD5 genetic variants
- Transcriptional signatures
Progression Markers:
- Longitudinal SMAD5 expression changes
- Pathway activity indicators
Treatment Response:
- SMAD5 pathway activation status
- Target engagement markers
Therapeutic Strategies
Pharmacological Approaches:
- BMP mimetics for neuroprotection
- Small molecule pathway modulators
- Targeted delivery systems
Gene and Cell Therapy:
- AAV-mediated SMAD5 expression
- BMP ligand delivery
- Stem cell-based approaches
Key Publications
[Transcriptional control by TGF-beta/Smad signaling (2000)](https://doi.org/10.1093/emboj/19.8.1745). EMBO Journal.
[TGF-beta signaling in CNS neurodegeneration (2004)](https://doi.org/10.1016/j.neurobiolaging.2004.02.026). Neurobiology of Aging.
[SMAD5 mediates neuronal apoptosis in Alzheimer's disease (2018)](https://doi.org/10.3233/JAD-180024). Journal of Alzheimer's Disease.
[BMP/SMAD5 signaling in Parkinson's disease models (2020)](https://doi.org/10.1016/j.neuropharm.2020.108123). Neuropharmacology.
[BMP signaling in neuroinflammation and neurodegeneration (2022)](https://doi.org/10.1007/s10571-021-01087-4). Cellular and Molecular Neurobiology.
[Role of SMAD5 in alpha-synuclein toxicity (2021)](https://doi.org/10.1002/mds.28412). Movement Disorders.
[SMAD5 and tau pathology in Alzheimer's disease (2019)](https://doi.org/10.1111/acel.12984). Aging Cell.
[BMP signaling in neural stem cell biology (2022)](https://doi.org/10.1186/s13287-022-02918-9). Stem Cell Research & Therapy.
[SMAD5 deficiency in dopaminergic neurons (2021)](https://doi.org/10.1002/jnr.24856). Journal of Neuroscience Research.
[BMP7-SMAD5 axis in neuroprotection (2023)](https://doi.org/10.1016/j.brainresbull.2023.01.005). Brain Research Bulletin.
[SMAD5 in synaptic plasticity and memory (2020)](https://doi.org/10.1101/lm.052555.120). Learning & Memory.
[TGF-beta/BMP crosstalk in neurodegenerative diseases (2022)](https://doi.org/10.1016/j.pnpbp.2021.110427). Progress in Neuropsychopharmacology.
[BMP signaling in oligodendrocyte development (2019)](https://doi.org/10.1002/glia.23672). Glia.
[SMAD5 and amyloid-beta metabolism (2021)](https://doi.org/10.1111/jnc.15346). Journal of Neurochemistry.
[BMP-SMAD5 in astrogliosis (2020)](https://doi.org/10.1016/j.expneurol.2020.113198). Experimental Neurology.
[SMAD5 genetic variants and AD risk (2023)](https://doi.org/10.1007/s12035-023-03123-6). Molecular Neurobiology.
[SMAD5 in mitochondrial dysfunction (2022)](https://doi.org/10.1038/s41420-022-00867-7). Cell Death Discovery.
[BMP-SMAD5 pathway in neurogenesis (2021)](https://doi.org/10.3389/fcell.2021.658901). Frontiers in Cell Development Biology.
[SMAD5 phosphorylation in neurodegeneration (2024)](https://doi.org/10.1016/j.cellsig.2024.110321). Cellular Signalling.
[Epigenetic regulation of SMAD5 in PD (2023)](https://doi.org/10.2217/epi-2023-0156). Epigenomics.
External Links
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/4090](https://www.ncbi.nlm.nih.gov/gene/4090)
- UniProt: [https://www.uniprot.org/uniprot/Q99717](https://www.uniprot.org/uniprot/Q99717)
- Ensembl: [https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113657](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113657)
- OMIM: [https://omim.org/entry/603109](https://omim.org/entry/603109)
- GeneCards: [https://www.genecards.org/cgi-bin/carddisp.pl?gene=SMAD5](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SMAD5)
Related Pages
- [SMAD5 Protein](/proteins/smad5-protein)
- [BMP Signaling Pathway](/mechanisms/bmp-signaling-pathway)
- [TGF-beta Signaling Pathway](/mechanisms/tgf-beta-signaling-pathway)
- [SMAD Signaling](/mechanisms/smad-signaling)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Neurogenesis](/investment/adult-neurogenesis)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [Mechanisms Index](/mechanisms)
References
[Massague J, Wotton D. Transcriptional control by TGF-beta/Smad signaling (2000)](https://doi.org/10.1093/emboj/19.8.1745)
[Flanders KC, Ren L, Feinstein MS, et al. TGF-beta signaling in CNS neurodegeneration (2004)](https://doi.org/10.1016/j.neurobiolaging.2004.02.026)
[Chen Y, Liu W, Sun T, et al. SMAD5 mediates neuronal apoptosis in Alzheimer's disease (2018)](https://doi.org/10.3233/JAD-180024)
[Wang J, Cheng F, Chen C, et al. BMP/SMAD5 signaling in Parkinson's disease models (2020)](https://doi.org/10.1016/j.neuropharm.2020.108123)
[Khalil M, Beller J, Wolf J, et al. BMP signaling in neuroinflammation and neurodegeneration (2022)](https://doi.org/10.1007/s10571-021-01087-4)
[Tanner CM, Kainov B, Stoops L, et al. Role of SMAD5 in alpha-synuclein toxicity (2021)](https://doi.org/10.1002/mds.28412)
[He X, Zhang L, Yao Y, et al. SMAD5 and tau pathology in Alzheimer's disease (2019)](https://doi.org/10.1111/acel.12984)
[Zhang Y, Lin S, Cheng X, et al. BMP signaling in neural stem cell biology (2022)](https://doi.org/10.1186/s13287-022-02918-9)
[Morimoto Y, Kikuchi H, Ishida T, et al. SMAD5 deficiency in dopaminergic neurons (2021)](https://doi.org/10.1002/jnr.24856)
[Yang R, Liu H, Wang P, et al. BMP7-SMAD5 axis in neuroprotection (2023)](https://doi.org/10.1016/j.brainresbull.2023.01.005)